Publicaciones en las que colabora con José Miguel López Novoa (43)

2022

  1. Functional Alterations Involved in Increased Bleeding in Hereditary Hemorrhagic Telangiectasia Mouse Models

    Frontiers in Medicine, Vol. 9

2021

  1. Pregnancy-induced high plasma levels of soluble endoglin in mice lead to preeclampsia symptoms and placental abnormalities

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-20

2008

  1. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction: Molecular Diagnosis

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 3, pp. 955-961

  2. L- and S-endoglin differentially modulate TGFβ1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts

    Journal of Cell Science, Vol. 121, Núm. 6, pp. 913-919

  3. S-endoglin expression is induced in senescent endothelial cells and contributes to vascular pathology

    Circulation Research, Vol. 103, Núm. 12, pp. 1383-1392

  4. Teaching integrative physiology using the quantitative circulatory physiology model and case discussion method: evaluation of the learning experience

    American Journal of Physiology - Advances in Physiology Education, Vol. 32, Núm. 4, pp. 304-311

  5. The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation

    Nephrology Dialysis Transplantation, Vol. 23, Núm. 11, pp. 3403-3411

2007

  1. Erratum: Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia (Human Molecular Genetics (2007) vol. 16 (13) (1515-1533) 10.1093/hmg/ddm069)

    Human Molecular Genetics

  2. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia

    Human Molecular Genetics, Vol. 16, Núm. 13, pp. 1515-1533

  3. Human recombinant erythropoietic agents do not induce changes in circulating levels of endoglin and vascular endothelial growth factor in anemic cancer patients

    Cancer Letters, Vol. 255, Núm. 1, pp. 71-76

2006

  1. Endoglin modulation of TGF-β1-induced collagen synthesis is dependent on ERK1/2 MAPK activation

    Cellular Physiology and Biochemistry, Vol. 18, Núm. 1-3, pp. 135-142

  2. Endoglin regulates cyclooxygenase-2 expression and activity

    Circulation Research, Vol. 99, Núm. 3, pp. 248-256

  3. Reduced angiogenic responses in adult endoglin heterozygous mice

    Cardiovascular Research, Vol. 69, Núm. 4, pp. 845-854

  4. Resveratrol inhibits gentamicin-induced mesangial cell contraction

    Life Sciences, Vol. 78, Núm. 20, pp. 2373-2377

  5. TGF-β1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells

    Kidney International, Vol. 70, Núm. 5, pp. 901-909

2005

  1. Gentamicin induces Jun-AP1 expression and JNK activation in renal glomeruli and cultured mesangial cells

    Life Sciences, Vol. 77, Núm. 18, pp. 2285-2298

  2. Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, Núm. 10, pp. 3685-3690

  3. Role of vascular nitric oxide in experimental liver cirrhosis

    Current Vascular Pharmacology, Vol. 3, Núm. 1, pp. 81-85

2004

  1. Endoglin expression regulates basal and TGF-β1-induced extracellular matrix synthesis in cultured L 6 E 9 myoblasts

    Cellular Physiology and Biochemistry, Vol. 14, Núm. 4-6, pp. 301-310

  2. Endoglin regulates nitric oxide-dependent vasodilatation.

    The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 18, Núm. 3, pp. 609-611